Kinetics of IL-6 and TNF-α changes in a canine model of sepsis induced by endotoxin

Veterinary Immunology and Immunopathology

Volumn 146, Issue 2, 2012, Pages 143-149

  Song, Ruhui ^a   Kim, Junhwan ^a   Yu, Dohyeon ^b   Park, Chul ^a   Park, Jinho ^a  

^a Chonbuk National University   (South Korea)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

Experimental septic model; Gene expression; IL 6; Sepsis; TNF a

Indexed keywords

ENDOTOXIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD ANALYSIS; CLINICAL EXAMINATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMATOCRIT; LEUKOCYTE COUNT; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SEPSIS;

ANIMALS; DISEASE MODELS, ANIMAL; DOG DISEASES; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; INTERLEUKIN-6; KINETICS; LIPOPOLYSACCHARIDES; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84862814776     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2012.02.008     Document Type: Article

References (17)

1. Bienvenu J., Monneret G., Fabien N., Revillard J.P. The clinical usefulness of the measurement of cytokines. Clin. Chem. Lab. Med. 2000, 38(4):267-285.
2. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., Schein R.M., Sibbald W.J. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101(6):1644-1655.
3. Calandra T., Glauser M.P. Cytokines and septic shock. Diagn. Microbiol. Infect. Dis. 1990, 13(5):377-381.
4. Creasey A.A., Stevens P., Kenney J., Allison A.C., Warren K., Catlett R., Hinshaw L., Taylor F.B. Endotoxin and cytokine profile in plasma of baboons challenged with lethal and sublethal Escherichia coli. Circ. Shock 1991, 33(2):84-91.
5. DeClue A.E., Williams K.J., Sharp C., Haak C., Lechner E., Reinero C.R. Systemic response to low-dose endotoxin infusion in cats. Vet. Immunol. Immunopathol. 2009, 132(2-4):167-174.
6. Hauptman J.G., Walshaw R., Olivier N.B. Evaluation of the sensitivity and specificity of diagnostic criteria for sepsis in dogs. Vet. Surg. 1997, 26(5):393-397.
7. Hesse D.G., Tracey K.J., Fong Y., Manogue K.R., Palladino M.A., Cerami A., Shires G.T., Lowry S.F. Cytokine appearance in human endotoxemia and primate bacteremia. Surg. Gynecol. Obstet. 1988, 166(2):147-153.
8. House R.V. Cytokine measurement techniques for assessing hypersensitivity. Toxicology 2001, 158(1-2):51-58.
9. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25(4):402-408.
10. Nemzek J.A., Siddiqui J., Remick D.G. Development and optimization of cytokine ELISAs using commercial antibody pairs. J. Immunol. Methods 2001, 255(1-2):149-157.
11. Okano S., Yoshida M., Fukushima U., Higuchi S., Takase K., Hagio M. Usefulness of systemic inflammatory response syndrome criteria as an index for prognosis judgement. Vet. Rec. 2002, 150(8):245-246.
12. Otto C.M. Sepsis in veterinary patients: what do we know and where can we go?. J. Vet. Emerg. Crit. Care 2007, 17(4):329-332.
13. Paterson R.L., Webster N.R. Sepsis and the systemic inflammatory response syndrome. J. R. Coll. Surg. Edinb. 2000, 45(3):178-182.
14. Rau S., Kohn B., Richter C., Fenske N., Kuchenhoff H., Hartmann K., Hartle S., Kaspers B., Hirschberger J. Plasma interleukin-6 response is predictive for severity and mortality in canine systemic inflammatory response syndrome and sepsis. Vet. Clin. Pathol. 2007, 36(3):253-260.
15. Tracey K.J., Cerami A. Tumor necrosis factor, other cytokines and disease. Annu. Rev. Cell Biol. 1993, 9:317-343.
16. Watanabe E., Hirasawa H., Oda S., Matsuda K., Hatano M., Tokuhisa T. Extremely high interleukin-6 blood levels and outcome in the critically ill are associated with tumor necrosis factor- and interleukin-1-related gene polymorphisms. Crit. Care Med. 2005, 33(1):89-97. discussion 242-243.
17. Yu D.H., Noh D.H., Song R.H., Park J. Ethyl pyruvate downregulates tumor necrosis factor alpha and interleukin (IL)-6 and upregulates IL-10 in lipopolysaccharide-stimulated canine peripheral blood mononuclear cells. J. Vet. Med. Sci. 2010, 72(10):1379-1381.